Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11β-hydroxydehydrogenase 1 (11β-HSD1)Shung Wu, Jeffrey A. Robl, Ramakrishna Seethala et al.|Bioorganic & Medicinal Chemistry Letters|2011Cited by 28
Discovery of Clinical Candidate 2-((2<i>S</i>,6<i>S</i>)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3′-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 InhibitorXiang‐Yang Ye, Jeffrey A. Robl, Stephanie Chen et al.|Journal of Medicinal Chemistry|2017Cited by 18